Navigation Links
A membrane-lid tube for bacteria cultivation and freeze-drying

Wilhelm Bockelmann, Institut fr Mikrobiologie, Bundesanstalt fr Milchforschung; Kiel, Germany
Susanne Wagner, Eppendorf AG Introduction Miniaturization plays an ever increasing role in everyday lab routines. Ongoing developments of tubes, pipettes, and pipette tips enable drastic reductions in the amount of material required. More economical use of reagents, the opportunity of using smaller sample quantities, and the elimination of bottlenecks thanks to reduced space requirements, save time and money and thus form the ideal prerequisites for increasing sample throughput.
The membrane-lid tube LidBac from Eppendorf is a significant contributory factor in the miniaturization process to the microbiological laboratory. For the first time ever, it is now possible to cultivate miniprep bacteria cultures in exactly the format required for the preparation. Following cultivation, the bacteria no longer have to be pipetted into a new tube since the culture is grown in the tube of the subsequent preparation. The automated production process enables the membrane-lid tube to be used directly, without need for prior sterilization. The cleaning process before and after cultivation, as required when conventional glass tubes are used, is no longer necessary. Target The experiments described in this article demonstrate the suitability of the membrane-lid tube LidBac for bacteria cultivation on a miniprep scale (1 to 2 ml). A comparison is made between the growth behavior of bacteria in LidBac and in conventional Erlenmeyer flasks.
The membrane-lid tube is suitable for virtually all stages of the experiment whenever ventilation, drying, or a similar step is necessary. This is underlined by a comparison of the results obtained by freeze-drying in LidBac with those produced in a standard tube. Material and methods
LidBac
LidBac consists of a polypropylene (PP) membrane-lid with an integrated PP hydrophobic membrane and a Safe-Lock microcentrifuge tube. The membrane is gas-permeable, hydrophobic,and impermeable to bacteria (0.2 m pore size). The membrane lid is compatible with all 1.5 ml and 2 ml Eppendorf Tubes. After the tube has been filled, the membrane-lid is simply pressed into the tube. As there is no hinged connection to the tube, the lid can be removed easily at any time to enable the tube to be used for follow-up applications. Bacteria cultivation Growth kinetics:
Four parallel experiments were carried out in order to investigate the growth behavior of Escherichia coli HB101 and Bacillus subtilis 168 when cultivated in LidBac. A positive control was carried out in parallel in the form of bacteria cultivation in Erlenmeyer flasks. To ensure an identical initial bacteria concentration in the different test tubes, LB (Luria Bertani) medium was given a 1% inoculation of overnight culture. After being mixed thoroughly, 1 ml bacteria culture each was transferred to 1.5 ml membrane-lid tubes (Eppendorf LidBac)and 5 ml each was transferred to a 50 ml Erlenmeyer flask with cellulose stopper.

The membrane-lid tubes were then incubated in the Eppendorf Thermomixer R at 1,400 rpm and 37C. The Erlenmeyer flasks were sealed with cellulose stoppers and incubated in a linear oscillating water bath (Kttermann, approx. 200 strokes/min, at 37 C). The growth kinetics of the bacteria were determined by means of absorption measurements at 620 nm.

Evaporation:

Evaporation experiments were carried out with water since no significant differences were expected from experiments with culture medium containing growth.

1 ml water was transferred into each 1.5 ml LidBac tube. The tubes were sealed with their membrane-lid and then incubated in the Thermomixer R at 37 C and 1,400 rpm (room temperature 22-23 C, relative humidity 45-50 %). As a positive control, 5 ml water was transferred into each 50 ml Erlenmeyer flask, which was then sealed with a cellulose stopper and incubated in a linear oscillating water bath at 37 C. The weight of the tubes was determined in five parallel measurements, carried out after 3, 6, 9,18, and 24 hours. Cell morphology:

Since the cell morphology of bacteria often changes when insufficient amounts of oxygen are supplied for example, under sub-optimal air conditions, long, thin nutrient-deprived phenotypes are formed in bacteria that normally grow in short, rodlike shapes an analysis of cell morphology of cultivated bacteria enables the tubes to be assessed in regard to their suitability for bacteria cultivation.

Following overnight cultivation, the bacteria strains E. coli HB101 (facultatively anaerobic) and B. subtilis 168 (strictly aerobic) were inoculated at a concentration of 1% into the LB medium. 1 ml of this medium was then transferred into each 1.5 ml LidBac tube and 5 ml of the medium was placed into each 50 ml Erlenmeyer flask. The vessels were then sealed (LidBac with its membrane-lid, the Erlenmeyer flasks with cellulose stoppers) and incubated under the same conditions as for bacteria cultivation. After 3, 6,16, and 24 hours, samples were removed from both vessel types and examined under a microscope. To prevent any effect on the morphology of the bacteria caused by the increase in the oxygen supply as a result of the tubes being opened, a new tube was used for each measurement. Freeze-drying In five parallel preparations, a comparison was made between freeze-drying (Beta 2-16, Christ, Osterode, Germany) E. coli HB101 in membrane-lid tubes and in standard tubes.

The medium used for lyophilization was 5 % lactose (in distilled water).

1 ml of each bacteria culture, grown in both LidBac and standard tubes, was pelleted in the early stationary phase (in the Eppendorf Centrifuge 5402 at 4 C and 14,000 x g), resuspended in 1 ml of 5 % lactose, centrifuged, and then diluted in 500 l /200 l medium.The LidBac tubes were then sealed with their membrane-lid and placed into a custom-made aluminum block with the corresponding bores. The standard tubes were transferred, unsealed, to the same block. For a eutectic point of the cultures in 5 % lactose of approx. 13 C, a vacuum of 1.03 mbar was set. To dry the samples, the heating temperature of the sample area was raised gradually from 5C to +5 C over a period of 12 hours. The sample temperature was monitored continuously using a Pt100 sensor. After 4, 8,12, and 24 hours, the samples were removed from the drying process and the residual volume in the tubes was determined. The drying process had to be interrupted briefly each time the samples were removed. Results of bacteria cultivation Growth kinetics:
The time required for the cultivation of E. coli HB101 / B. subtilis 168 in LidBac corresponds to the usual times for 5 ml cultures in Erlenmeyer flasks (see Figs. 1 and 2). Undelayed growth was possible with both tube types and bacteria species up to an absorption of 1.8.

Sealed Safe-Lock microcentrifuge tubes (1.5 ml filled with 1ml culture) were selected as a negative control. The cell concentrations obtained in these tubes were much lower. Evaporation:
The assumption that evaporation phenomena are independent of the medium used (LB or water) was confirmed by the results of the growth of E. coli HB101 (results not shown).

Whereas there was virtually no evaporation with Erlenmeyer flasks that had been sealed with cellulose stoppers, the membrane-lid tubes displayed negligible evaporation values (< 7 % in 6 hours; approx. 20 % in 16 hours) (results not shown).

Cell morphology:
During both cultivation processes, no differences in cell morphology were noted with E. coli HB101 or with B. subtilis 168. Results of freeze-drying The speed at which solutions are freezedried in membrane-lid tubes corresponds to the requirements of standard protocols. It is possible to freeze-dry 500 l medium completely within 12 -13 hours and 200 l within 8 hours (see Fig. 3). Drying in the open standard tubes was quicker than in LidBac tubes. Discussion The experiments mentioned here were carried out to test the suitability of the membrane-lid tube LidBac both for bacteria cultivation as well as for freeze-drying.

The results show virtually identical growth behavior of the bacteria cultivated in LidBac in comparison to conventional cultivation methods in Erlenmeyer flasks. The same bacterial densities were achieved within the usual times. The slight concentration of the culture during incubation, caused by the vapor permeability of the membrane, had no adverse effect on the growth behavior of the bacteria.

The experiments showed that LidBac is also suitable for lyophilization. Although freeze-drying in the membrane-lid tube is slower than in open tubes, it still meets the requirements of standard protocols. It is possible to dry biological samples within one working day or overnight. The main advantage is the sterile condition achieved by the bacteria-proof membranelid when LidBac is used. Conversely, when open tubes are used, the chemical sterilization of the drying chamber of the freeze-dryer requires a lot of time and effort. For this reason, sterile conditions are rarely achieved in laboratory freezedrying units, and are not necessary when LidBac is used. Summary LidBac is a quick and easy way to eliminate several work steps, reduce the quantities of media required, save space in the lab, and simplify drying processes under sterile conditions.


'"/>

Source:


Page: All 1 2 3 4 5 6 7

Related biology technology :

1. A simple method to sequence from bacterial colonies using [a-33P] radiolabeled ddNTPs and Thermo Sequenase
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: membrane lid tube for bacteria cultivation and freeze drying

(Date:5/20/2015)... May 20, 2015 This year has ... for lawns. US Patented Pearl’s Premium Ultra Low ... around the country that are coming out of record ... a number of major global concerns related to water, ... grass – the alternative to the standard, water-wasting, chemical-treated ...
(Date:5/20/2015)... The global genotyping market is expected to grow at ... 2015 to 2020 to reach $17.0billion in 2020. Genotyping ... development process and to provide personalized therapy, factors that ... by key manufacturers to offer advanced and innovative products ... 113 market data tables & 37 figures spread through ...
(Date:5/20/2015)... 2015  Marc Tessier-Lavigne, president of The Rockefeller ... million from The Marie-Josée and Henry R. Kravis ... that will be the centerpiece of the University,s ... R. Kravis Research Building, two stories high, will ... three city blocks following the shoreline of the ...
(Date:5/20/2015)... 20, 2015  Resolution Bioscience announced today the successful ... TM , a blood-based liquid biopsy for an ALK-gene ... (NSCLC), the most common form of this cancer. Researchers ... patients to personalized therapies and direct them into clinical ... Department of Health, the CLIA authority in ...
Breaking Biology Technology:Breakthrough 4th Generation Low Maintenance Lawn Seed Offers Solution to California Drought 2Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 2Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 3Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 4Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 5The Marie-Josee and Henry R. Kravis Foundation Provides Landmark Gift of $100 Million to The Rockefeller University 2The Marie-Josee and Henry R. Kravis Foundation Provides Landmark Gift of $100 Million to The Rockefeller University 3The Marie-Josee and Henry R. Kravis Foundation Provides Landmark Gift of $100 Million to The Rockefeller University 4Resolution Bioscience Receives CLIA Certification for its Diagnostic Laboratory and Launches CLIA-Certified Liquid Biopsy for Lung Cancer 2
... March 18 Johnson & Johnson,Pharmaceutical Research ... received an approvable letter from the U.S. ... Drug Application (NDA) for,ceftobiprole for the treatment ... diabetic foot infections., J&JPRD, along with ...
... 18 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.,(TSX: ONC, NASDAQ: ... U.S. Patent 7,344,711 entitled "Use of Adenoviruses Mutated ... describe methods of treating,cancer using adenoviruses that are ... an activated Ras pathway., "This patent expands ...
... REDWOOD CITY, Calif., March 18 Ingenuity ... life science researchers, has,announced that they have ... GlaxoSmithKline for access to Ingenuity Pathways Analysis,(IPA) ... provide enterprise-wide,IPA access to researchers for rapid ...
Cached Biology Technology:FDA Issues Approvable Letter for Ceftobiprole for Treatment of Complicated Skin Infections 2Oncolytics Biotech Inc. Announces Issuance of 26th U.S. Patent 2Ingenuity Systems Extends Enterprise-Level Software Agreement With GlaxoSmithKline 2
(Date:5/11/2015)... , May 11, 2015  Through a well-rounded UAS delegation ... had a strong showing at AUVSI,s Unmanned 2015 conference ... of Ohio,s UAS industry met with ... from all points along the UAS ecosystem. ... (DDC) Vice President for Aerospace Rich Knoll . "If ...
(Date:5/8/2015)... JOSE, Calif. , May 8, 2015 Synaptics ... interface solutions, today announced that members of the executive management ... J.P. Morgan 43rd Annual Technology, Media and Telecom Conference ... Waterfront Hotel in Boston, MA ... May 27, 2015 Time: 2:45pm ET Location: The New York ...
(Date:5/5/2015)... Conn. , May 5, 2015, NXT-ID, Inc. ... authentication company focused on the growing mobile commerce market, reminds ... Company,s Chief Technology Officer, is presenting  at CARTES SECURE CONNEXIONS ... May 5-7, 2015. The three-day conference is ... David is speaking in is themed Global Fraud: Where ...
Breaking Biology News(10 mins):Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2Synaptics to Present at Upcoming Investor Conferences 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3
... Houston as a result of chemical pollution produced by manufacturing ... to a new study. But the new findings ... -- come with a catch, says a team of scientists ... CIRES, a joint institute of the University of Colorado at ...
... PARK, Md. - The University of Maryland, in partnership ... Maryland Baltimore County, has received a $7.9 million federal ... Resonance (NMR) magnet that will help researchers unravel the ... cancer, AIDS and other diseases. The grant is ...
... are reporting this week new study results they say provide ... from bone marrow for patients suffering from acute lung injury, ... intensive care units. Led by Drs. Michael A. Matthay ... the University of California, San Francisco, the team writes in ...
Cached Biology News:Texas petrochemical emissions down, but still underestimated, says study 2University of Maryland partnership receives $7.9M from NIH for superconducting research magnet 2University of Maryland partnership receives $7.9M from NIH for superconducting research magnet 3Using bone marrow stem cells to treat critically ill patients on verge of respiratory failure 2Using bone marrow stem cells to treat critically ill patients on verge of respiratory failure 3
Cross reactivity to St. Louis encephalitis (MSI-7) is determined by ELISA....
EGTA, 10 g. Ethylene glycol-O,O-bis-[2-amino-ethyl]-N,N,N,N,-tetraacetic acid.Assay: > 99.0%. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
RABBIT ANTI HUMAN ATR (aa2122-2380) Immunogen: Human ATR peptide, amino acids 2122-2380...
casein kinase 2, alpha 1 polypeptide, transcript variant 2, mRNA (cDNA clone MGC:15232 IMAGE:4121882), complete cds...
Biology Products: